- Docket No.
- 4:23-cv-03560
- District Court
- Texas Southern
Goal
- Declaration that conduct violates antitrust law
- Enjoin alleged anticompetitive practices
Issues
Litigation Content
Why this Matters
The Federal Trade Commission alleges that a provider of anesthesia services and a private equity firm violated federal antitrust law by engaging in various practices to consolidate and monopolize the anesthesiology market in Texas. The monopolization of specialty health care services enables providers to maintain greater leverage within the commercial market and further drive up health care costs.
Potential Impact
The increasing consolidation of certain health care services by private equity-backed groups and the resulting impact on competition within health care markets could lead to higher costs and lower-quality care for patients.
11 Major Filings
- LETTER (Apr 11, 2024)
- ORAL ARGUMENT TRANSCRIPT (Apr 8, 2024)
- JOINT DISCOVERY PLAN (Apr 5, 2024)
- REPLY IN SUPPORT OF MOTION TO DISMISS OF WELSH CARSON (Feb 26, 2024)
- REPLY IN SUPPORT OF USAP'S MOTION TO DISMISS (Feb 26, 2024)
- OPPOSITION TO USAP's MOTION TO DISMISS (Jan 19, 2024)
- OPPOSITION TO WELSH CARSON ENTITIES' MOTION TO DISMISS (Jan 19, 2024)
- PROPOSED AMICUS BRIEF (American Investment Council) (Nov 27, 2023)
- WCE'S MOTION TO DISMISS (Nov 20, 2023)
- USAP's MOTION TO DISMISS (Nov 20, 2023)
- COMPLAINT (Sep 21, 2023)